Varicose veins are a health issue

According to the Ministry of Health, about 70% of the adult population have some type of varicose veins. 1
 
Varicose veins are dilated and tortuous veins in the legs, which present a phenomenon called reflux. These veins should carry the blood from the legs to the heart, but part of the blood flow follows in reverse (down to the feet)1.
 
The first aspect to be addressed when it comes to varicose veins is the demystification that this is a purely aesthetic problem. A patient with varicose veins suffers from swelling, leg pains, tiredness and cramps. And when the patient does not receive adequate treatment, the condition can progress to something much more serious, such as varicose ulcers or thrombophlebitis 2.
 
The main factor for the development of varicose veins is genetic, but obese patients or with professions that require unfavorable posture positions, such as standing, with little movement for long periods are more likely to develop the disease 1.
 
In Brazil, more than 30% of people over the age of 40 have varicose veins in some degree. They occur more predominantly in women, mainly due to hormonal factors and also due to pregnancy 3.
 
There are different alternatives for the treatment of varicose veins, among them the surgery (much used practice). In recent times, the technique of foam sclerotherapy has also gained space in the media and the medical practices.
 
There are also less invasive treatments, such as medications. Among the most used are flavonoids, such as diosmin and hidrosmin, for symptomatic treatment of varicose veins and other symptoms related to Chronic Venous Insufficiency, such as leg pain, burning sensation, swelling.4
 
Each patient needs an individualized indication. Varicose veins are a disease like any other, and there are several treatment options. The important thing is to visit an angiologist when the first symptoms are notices, and follow up regularly 1.
 
 
Ref.:
1) Czezacki A. Ministério da Saúde aprova nova técnica para combater as varizes no SUS. Blog da Saúde – Ministério da Saúde, 2017.
2) Sobreira ML, Yoshida WB, Lastoria S. Tromboflebite superficial: epidemiologia, fisiopatologia, diagnóstico e tratamento. Jornal Vascular Brasileiro, 2008.
3) Lins EM, Barros JW, Appolonio F, et al. Perfil epidemiológico de pacientes submetidos a tratamento cirúrgico de varizes de membros inferiores. J VascBras 2012, Vol. 11, Nº 4.
4) Venula: hidrosmina. Bula do medicamento. Biolab Sanus Farmacêutica, 2018.
April | 08 | 2019
arrow_backward See more articles
Customer Service 0800 724 6522
faleconosco@biolabfarma.com.br
Be connected